Point72 Hong Kong’s Imperva, Inc. IMPV Stock Holding History

Point72 Hong Kong’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-623	Closed	-$29K	–	1371
2018 Q3	$29K	Buy	+623	New	+$30.1K	0.01%	553
2018 Q2	–	Sell	-31	Closed	-$1K	–	1336
2018 Q1	$1K	Buy	+31	New	+$1.39K	﹤0.01%	862
2017 Q2	–	Sell	-30	Closed	-$1K	–	1139
2017 Q1	$1K	Buy	+30	New	+$1.25K	﹤0.01%	703

Other funds holding IMPV

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Point72 Hong Kong's IMPV Position: Q4 2018 in Review

Point72 Hong Kong sold out of Imperva, Inc. (IMPV) in Q4 2018, closing a stake of 623 shares — an estimated $29K sold.

Point72 Hong Kong first reported a position in IMPV in Q1 2017 and held it in 3 quarters. The position peaked at $29K in Q3 2018. 162 funds tracked by Wall St. Rank hold IMPV as of Q4 2018.

Point72 Hong Kong reported no remaining Imperva, Inc. position as of Q4 2018 after selling out during the quarter.
Point72 Hong Kong sold 623 Imperva, Inc. shares in Q4 2018, an estimated $29K.
Point72 Hong Kong first reported a position in Imperva, Inc. in Q1 2017 and held it in 3 quarters.
Point72 Hong Kong's Imperva, Inc. position peaked at $29K in Q3 2018.
162 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2018.

Based on Point72 Hong Kong's 13F filing for Q4 2018, filed 14 Feb 2019.